For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Evelo Biosciences, Inc.

USPTO Granted Patents = 14

% Expired Patents = 28.6

EPO Patents = 1

Trademarks = 3

Forward Citations = 63

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Brian Goodman (8 out of 9 patents)

Holly Ponichtera (7 out of 7 patents)

David Arthur Berry (6 out of 87 patents)

4. Shaila Rahman (6 out of 9 patents)

5. Maria Sizova (6 out of 6 patents)

6. Johanne Kaplan (6 out of 18 patents)

7. Andrea Itano (4 out of 4 patents)

8. Taylor A Cormack (4 out of 4 patents)

9. Carolina Baez-Giangreco (3 out of 3 patents)

10. Peter Sandy (3 out of 3 patents)

11. Jacqueline Papkoff (3 out of 3 patents)

12. Humphrey Gardner (3 out of 3 patents)

13. Noubar Boghos Afeyan (3 out of 77 patents)

14. Kritika Ramani (2 out of 2 patents)

15. Baundauna Bose (2 out of 3 patents)

14 patents: Sort by Forward Citations

1. 11672834 - Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome (2023-06-13),

2. 11612622 - Probiotic compositions containing clostridiales for inhibiting inflammation (2023-03-28),

3. 11607432 - Probiotic compositions containing clostridiales for inhibiting inflammation (2023-03-21),

4. 11524037 - Bacterial extracellular vesicles (2022-12-13),

5. 11266700 - Compositions and methods for treating immune disorders using immune modulatingbacteria strains (2022-03-08),

6. 11241461 - Treating cancer using a blautia strain (2022-02-08),

7. 11090341 - Compositions and methods for treating cancer and immune disorders usingbacteria (2021-08-17),

8. 10980845 - Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome (2021-04-20),

9. 10869903 - Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease (2020-12-22),

10. 10792314 - Compositions and methods of treating cancer usingssp. (2020-10-06),

11. 10702561 - Pharmaceutical compositions comprising astrain (2020-07-07),

12. 10576111 - Method of treating cancer usingssp.strain PTA-125097 (2020-03-03),

13. 10493113 - Compositions and methods for treating disease using astrain (2019-12-03),

14. 9603878 - Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease (2017-03-28),

Company Overview

Evelo Biosciences, Inc., based in Cambridge, MA, focuses on developing innovative therapies that harness the power of the microbiome to treat various diseases. The company specializes in the research and development of oral biologics, aiming to create a new class of medicines that can modulate the immune system and improve patient outcomes. Evelo's approach integrates advanced scientific insights with a commitment to transforming healthcare through novel therapeutic strategies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

14 Patents

#182 in Cambridge, MA

#1,359 in Massachusetts

#22,302 in US

#42,199 in the World

Cambridge, MA, United States of America

Evelo Biosciences, Inc.

Forward Citations = 63

25 inventors:

Brian Goodman (8 out of 9 patents)

Holly Ponichtera (7 out of 7 patents)

David Arthur Berry (6 out of 87 patents)

4. Shaila Rahman (6 out of 9 patents)

5. Maria Sizova (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Evelo Biosciences, Inc.. Retrieved from https://idiyas.com/company/evelo-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…